Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Sarcoma 1

Conditions

Gastrointestinal Stromal Tumors 1

Interventions

Specimen Handling 36 Magnetic Resonance Spectroscopy 31 Cyclophosphamide 26 Doxorubicin 23 Biopsy 22 pembrolizumab 21 Temozolomide 21 X-Rays 17 Radiotherapy 17 Radiation 16 Nivolumab 13 atezolizumab 12 Vincristine 12 Phantoms, Imaging 12 Irinotecan 12 Ifosfamide 12 Gemcitabine 12 fludarabine 11 cabozantinib 10 liposomal doxorubicin 8 Surgical Procedures, Operative 8 Ipilimumab 8 Etoposide 8 Bevacizumab 8 Paclitaxel 7 Immunoglobulin G 7 Carboplatin 7 palbociclib 6 olaparib 6 fludarabine phosphate 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

pemigatinib × Sarcoma × 90 days × Clear all

NCT07434843 2026-05-22

PEMIGIST

Dana-Farber Cancer Institute

Phase 2 Recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡